Clinical trials of a new heart drug have been halted because of concerns over Brexit. The BBC reports medical research company Recardio was due to try the drug dutogliptin on patients in Clydebank, Leeds and Exeter. It has suspended all UK activities due to uncertainty about how new medicines will be approved after Brexit. The … Continue reading Brexit fears stop clinical trials in the UK